Technology | May 02, 2013

Simbionix Releases New Structural Heart Procedure Simulator Models

Simbionix ANGIO Mentor Structural Heart Simulator Models

May 2, 2013 — Simbionix USA Corp. released various training modules for the Angio Mentor endovascular simulator.

The Simbionix Angio Mentor is a virtual reality-training simulator, providing hands-on practice in a simulated environment for endovascular procedures. This multidisciplinary system provides a training solution for a variety of procedures. An ever-expanding library of modules supports the acquisition and honing of essential skills to build confidence and proficiency in endovascular techniques and procedures.

Teaching endovascular basic skills requires a teaching physician's time and attention, and may be unsafe if performed on a live patient. The first set of the new Angio Mentor modules is intended for novice physicians to acquire necessary fundamental skills both for basic level wire-catheter, and core electrophysiology skills. These modules are set in a game-like environment and will allow training in a user friendly, enjoyable and safe setting. For the first time physicians will have the opportunity to learn and practice in both non-anatomic and on an anatomical vascular model, in an interactive challenging setting.

The next set of modules is for practicing procedures for the treatment of structural heart diseases. These are demanding and complicated procedures, involving innovative technologies, which need to be learned in depth. One of the features of these modules is that they provide much needed practice in the introduction and interpretation of live echo, using both intra-cardiac echo (ICE) and transesophageal echo (TEE). The procedures covered are atrial septal defect (ASD)/patent foramen ovale (ASD) closure, left atrial appendage (LAA) closure, transcatheter aortic valve implantation (TAVI) and transseptal puncture.

Simbionix is also introducing self-guided cases for LAA closure and transseptal puncture, in which the cardiologist/electrophysiologist may learn how to perform the procedure using the module's step-by-step real time instructions, visual aids and live procedure videos.

"We are maintaining our commitment and investment in the continuous education for endovascular surgeons in all phases of their career, from learning basic and fundamental skills through complicated and high risk procedures," said Inbal Mazor, Simbionix VP of global marketing. "Working hand-in-hand with the medical community and the medical device industry has helped us better understand the need to provide a cutting edge training experience within our simulation platform. These unique new modules join the ever-growing library of training modules being developed for the Angio Mentor, aimed to support the fast developments in the field of vascular interventions."

Experience the latest additions to the Angio Mentor at one of the following events during SCAI, May 8-11 in Orlando, Fla.; HRS, May 8-11 in Denver, Colo.; ESVB, May 10-11, France; and EuroPCR, May 21-24, France.

For more information: www.simbionix.com

Related Content

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

News | Cath Lab | July 22, 2021
July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of
ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.
News | Cath Lab | July 14, 2021
July 13, 2021 — East End Medical announced it received U.S.
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone.

Feature | Cath Lab | May 14, 2021 | By Dave Fornell, Editor
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal fun
Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting proc

Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Cath Lab | May 12, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.

Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images

Getty Images

News | Cath Lab | May 03, 2021
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for sta
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
News | Cath Lab | April 29, 2021
April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American
There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

News | Cath Lab | April 28, 2021
April 28, 2021 – Results from a retrospective observational study, presented today at...
A cardiac cath lab at Henry Ford Hospital in Detroit. Photo by Dave Fornell

A cardiac cath lab complex PCI case at Henry Ford Hospital in Detroit. Photo by Dave Fornell

News | Cath Lab | April 28, 2021